Category: Federal Forum Posters
Purpose: Prior to April 2017 at the Hershel “Woody" Williams VA Medical Center in Huntington, WV, a clinical pharmacist or pharmacy resident would be on-call to provide an initial vancomycin dosing regimen using population pharmacokinetic parameters. In 2017, a new algorithm was created to decide on an initial vancomycin dose based on the patient’s weight and renal function, which eliminated the need to contact a clinical pharmacist after-hours to determine the dose. The purpose of this study is to analyze the differences between utilizing on-call clinical pharmacists and the initial dosing algorithm in patient outcomes.
Methods: A retrospective chart review will be conducted to evaluate the efficacy of a vancomycin dosing regimens from tradition on-call clinical pharmacist dosing to that of the new vancomycin protocol. Specific events for evaluation include: time to initiation of first vancomycin dose, efficacy of vancomycin dosing based on trough levels, serum creatinine, and white blood cells. Patient’s with accurately timed vancomycin troughs collected appropriately will be analyzed. The labs closest to the initiation of vancomycin therapy will also be analyzed to compare available lab work before and after the patient received vancomycin therapy.
Results: Collection of data in-process. Will present final results at the 2018 Midyear Clinical Meeting.
Conclusion: Collection of data in-process. Will present final results at the 2018 Midyear Clinical Meeting.
Megan Bankert– Pharmacy Resident, Hershel, Huntington, WV